Polypharmacy

From WikiMD's WELLNESSPEDIA

Polypharmacy is the concurrent use of multiple medications by a patient, especially when too many forms of medication are used by a patient, i.e., more than are medically necessary. Healthcare providers, including doctors and pharmacists, often use these terms when they refer to the increasing number of medications used by elderly patients (65 years and older), and more generally in any patient.

Definition[edit]

The term polypharmacy lacks a standard definition, as there are multiple different descriptions. Some definitions focus on the process of prescribing, while others focus on the impact of taking multiple medications. Simultaneously, the numerical thresholds used vary in the literature, with ranges from two or three to 11 or more.

Prevalence[edit]

The prevalence of polypharmacy is high among the elderly, with estimates ranging from 40% to 80%. The prevalence of polypharmacy is also increasing over time. In a study of elderly patients in Sweden, the prevalence of polypharmacy increased from 44% in 2005 to 58% in 2014.

Risks[edit]

Polypharmacy is associated with an increased risk of adverse events, including falls, delirium, and adverse drug reactions. It is also associated with increased healthcare costs and a higher risk of hospitalization.

Management[edit]

The management of polypharmacy involves regular review of the patient's medications, with the aim of reducing the number of unnecessary medications. This process is known as deprescribing.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.